Reports suggest Anthropic's upcoming IPO could beat the record for the largest in history. The author expects Broadcom to benefit, as Anthropic reportedly plans major AI infrastructure build-outs and has a five-year agreement worth $161.2 billion for TPU-based compute capacity with Broadcom. Broadcom projects $115 billion in AI revenue for fiscal 2027 and $230 billion for fiscal 2028, though a growing AI chip share could lower gross margins. In contrast, Recursion Pharmaceuticals, founded in 2013, still has no drug on the market, and Anthropic, which says nine of the 10 largest pharma companies are among its clients, could erode its AI drug-discovery edge. The author finds Recursion's stock unattractive given clinical and regulatory uncertainty.
Summary written by Upside AI from the original article. Read the source for full details.
Read the original on Yahoo Finance ↗
Keywords
IPOAnthropicartificial intelligenceBroadcomNVDA
Open a keyword to see other news on the same topic.
Related tickers and likely impact
NVDA
• NeutralNvidia
Relevance: low
| Market | US stocks |
|---|---|
| Sector | Information Technology |
| Industry | Semiconductors |
| Market cap | $5.1T |
| Close on 10/30/2026 | 204.81 |
| Change that session | -4.14% |
Impact is scored by AI from the headline and may be wrong. It is not investment advice.
Related news
- Broadcom Rises 3% on DA Davidson Upgrade and $400 Target Tied to Anthropic IPO; NVIDIA and AMD Edge Higher
Broadcom (AVGO) rose 3% to $339.90 in early trade after DA Davidson upgraded the stock to Buy from Neutral and set a $400 price target, citing Anthropic's IPO filing. The filing names Broadcom as a supplier and lessor of Anthropic's AI computing equipment under non-cancelable five-year leases for TPU-based capacity, and Anthropic put cash into a restricted account for Broadcom's benefit in April. Broadcom's AI semiconductor revenue reached $16.7 billion in Q3 FY2026, up 221% year over year, with a Q4 FY2026 outlook of $21.7 billion. The article says this growth depends on a few customers whose funding is not yet secured, and that the leases can accelerate on certain payment or performance defaults. NVIDIA rose 1% to $218.41 and AMD 2% to $544 as chip stocks gained.
- Why Broadcom Stock Rallied Tuesday Morning
Broadcom (AVGO) rose as much as 5% on Tuesday and was still up 3.5% at 11:20 a.m. ET, after DA Davidson analyst Gil Luria upgraded the stock and raised his price target to $400 from $350, implying potential upside of 22% from Monday’s close. After reviewing Anthropic’s regulatory filing ahead of its IPO, Luria noted that Broadcom is both a supplier and lessor to the AI start-up, with a non-cancelable five-year lease and deposited funds to secure compute capacity, which provides visibility into part of Broadcom’s future AI chip business. A Wall Street Journal report said CEO Hock Tan lobbied banks and private equity firms to help Anthropic secure $63 billion in financing for TPUs being developed with Google. Broadcom trades at 29 times forward earnings and 17 times next year’s expected earnings, which may look pricey, but the article cites its 0.43 PEG ratio and triple-digit growth as reasons it is reasonably priced.
- 3 Major Risks With Anthropic's IPO
Anthropic has filed its IPO prospectus, in which management claims a $40 trillion total addressable market and revenue growth of 1,300% in the first half of the year versus the same period of 2025. The article highlights three risks: competition from Gemini, ChatGPT, low-cost models like DeepSeek and on-device AI; rising compute costs, with $265.6 billion in future commitments under some agreements and more than $500 billion estimated for others; and a capital structure in which a founding-team LLC holds one share carrying 50.1% of voting rights, which may limit Class A shareholders' influence over key decisions, including a change of control. In Q2, compute and infrastructure expenses rose 300% against 1,368% revenue growth, a gap the author says may not last.
- Jim Cramer sees more pain for beaten-down AI stocks: ‘I think it’s too soon to say the coast is clear’
The Nasdaq CTA Artificial Intelligence Index, which tracks 58 AI-linked stocks, fell 7.0% over the last month, while the AIQ ETF rose just 0.12% over three months. In his October 18 Investing Club column, Jim Cramer said it is too soon to return to the hardest-hit AI data center stocks and wants to see improved charts, hyperscaler reports, the end of the U.S. election and the Anthropic IPO first. Stockatomics founder Monte Malukas said his AI Infrastructure Index is up about 70% over the past year and memory chip prices have risen nearly fivefold, and he would watch hardware prices and shipment volumes as early signs of weaker demand. Meta reported negative free cash flow of $2.12 billion in Q3 2026 and expects 2026 capex of $135–145 billion, while Harry Hamann of InvestWealth.com said Microsoft, Alphabet, Amazon and Meta point to about $700 billion of capex in 2026. The Anthropic IPO, expected in mid-to-late November at an estimated $1.5–2 trillion valuation, is seen by some as a test of whether AI companies can turn demand into profit.
- The Smartest AI Stock to Buy on Anthropic's IPO Filing Isn't Anthropic
Anthropic has filed an S-1 with the SEC, signaling a future IPO, and lists Nvidia among its major industry partners. The author notes Anthropic uses multiple chips, and Nvidia's GPUs are heavily used in cloud environments where customers run Claude-based products. Nvidia expects global AI data center capital expenditures to reach $3 trillion to $4 trillion annually by 2030 and has guided for 70% revenue growth in 2027. Yet the stock trades at about 23 times this year's earnings estimates, 13.6 times next year's, and 27 times trailing earnings, which the author says does not reflect growth beyond 2026. The author argues Nvidia remains a strong AI investment, and other companies' 2027 spending plans could confirm that view.
- Neocloud Stocks Have Sunk by More Than 30% This Month. What Does That Mean for Anthropic's IPO?
Shares of neocloud AI infrastructure firms CoreWeave, Nebius Group and IREN have each fallen more than 30% this month, as Anthropic prepares a major IPO. Neoclouds have fewer revenue streams and less financial flexibility than large cloud providers, so heavy borrowing becomes riskier when rates rise or customers cut spending, and Gartner warned up to 80% could stop operating independently by 2030. Anthropic's IPO filing shows first-half 2026 revenue of $16.3 billion, up about 1,300% year over year, and more than 11,900 customers paying at least $100,000 a year. It also reported an $80.7 billion net loss, about $72.4 billion of it from noncash accounting adjustments, along with long-term computing commitments and roughly $131.7 billion in cash and short-term investments at the end of June. The article says Anthropic could be valued at $1.5 trillion to $1.75 trillion, and the sell-off suggests investors are becoming more discerning about AI valuations.
Related markets
Latest news
- Prediction: This Will Be Palantir's Stock Price by the End of 2027
Palantir's shares are up almost 700% over five years, but its rally has slowed over the past 12 months. Demand for its AI-powered data analytics has been strong: second-quarter revenue rose 93% year over year to $1.94 billion, with U.S. commercial clients up 149%. The company does not build its own AI models and works with third-party APIs, while its work with government clients such as the CIA, NATO and the Department of Defense may support its security reputation. The article cites a forward P/E of 89 versus the S&P 500 average of 19 as a key concern, along with political risks such as its work with ICE. Assuming a return near the S&P 500's roughly 10% annual average, it estimates a price around $216 by end-2027 from $197 on Oct. 29, and suggests investors may wait for a cheaper price before taking a large position.
- Many Pharmaceutical Companies Face Banks Tightening Debt Collection
Several pharmaceutical companies are facing banks seizing collateral, including inventory, machinery, factories and real estate, to recover debts. VietinBank Hà Giang is selecting an auction organization to handle the debt of over 33.51 billion VND owed by CTCP TW 65 as of 21/10/2026, comprising principal of nearly 29.85 billion VND, accrued interest of over 3.09 billion VND and penalty interest of about 572 million VND. BAMC has announced the seizure of several assets of CTCP Dược liệu Việt Nam to settle debt with BIDV Hà Nội, including an 8,256.8 m² site in Phú Thọ housing a GMP-WHO factory and drug production lines, a 977.2 m² plot in Đà Nẵng, a 591.3 m² plot in Đồng Nai and a villa at Vinhomes Riverside in Hà Nội. For CTCP Dược Y Đức, the bank requested asset handover from 11/9/2026, but the parties had not complied, and two Hà Nội properties were placed under seizure. Separately, a 130.5 m² plot in Vinh City, Nghệ An, securing a loan of CTCP Vitamec, is being auctioned at BIDV Hùng Vương.
- Silver Falls Below $50/Ounce: What Lies Ahead?
Silver has broken below $50/ounce and is weakening more than gold, with prices hitting the lowest levels since the start of the year. A Metals Focus report expects the market to shift from deficit to surplus in 2027, as inventories rise and jewelry and industrial demand slow; high prices and efforts to use less silver, especially in solar panels, also weigh on demand. Interest rates add pressure: the Fed held rates in October but signaled readiness to tighten further, markets price an 80% chance of a 25 basis point hike in December, and rising yields reduce the appeal of precious metals. London vault stocks reached 932 million ounces, with about 267 million ounces available for trading excluding ETP holdings, nearly double the October 2025 low, as silver held in ETPs fell by about 60 million ounces this year. The report says silver will likely keep following gold over the next 12 months, and the outlook could change if expectations of tighter monetary policy in 2027 ease.
- After Eli Lilly’s Explosive Earnings Report, Is It Too Late to Buy the Stock?
Eli Lilly reported third-quarter revenue up 39% to more than $24 billion, driven mainly by its weight loss portfolio. Mounjaro sales rose 65% to over $10 billion and Zepbound climbed 49% to $5.3 billion, while 40% of new patients starting an oral obesity medicine chose Foundayo. Lilly holds 63% of the U.S. market, and the stock is trading at a record high above $1,300, at 42x forward earnings estimates versus more than 70x in 2024. The article argues the weight loss market still has room to expand, since only 3% to 10% of potential U.S. patients access weight loss care, and that late-stage candidates such as retatrutide add to the growth outlook.
- Nvidia (NVDA) CEO Jensen Huang Reportedly Targeted In Chinese Espionage Plot
Reports say Nvidia CEO Jensen Huang was targeted in an alleged Chinese espionage plot. The reported operation has prompted fresh questions from US lawmakers about potential security vulnerabilities in Nvidia's AI chip development. Regulators and legislators are weighing the incident against existing restrictions on Nvidia's advanced AI chip exports to China. The article argues the episode could reinforce Washington's view of Nvidia as critical AI infrastructure, while also potentially hardening support for stricter licensing and oversight of where its top-end platforms are deployed, which could cap part of the addressable market.
- Shopify Stock Is More Than 10% Below Its Record. Should You Buy Before Its Nov. 3 Report?
Shopify (SHOP) closed at a record $179.22 on Oct. 12 but now trades about 12% below that level, including a roughly 6% drop on Friday. The e-commerce software company reports third-quarter results before the market opens on Nov. 3, after management set guidance in August for revenue growth in the low thirties, gross profit growth in the mid-to-high 20s and a free cash flow margin in the high teens to low 20s. The author notes Shopify has met or beaten its guidance all year, with revenue growth of 34% in both the first and second quarters, though the third quarter faces a tougher comparison. Shares fell about 16% on May 5 even though first-quarter revenue growth beat the outlook, and rose about 17% after the August report, suggesting investors judge more than guidance beats. At roughly 86 times trailing free cash flow, the author argues the drop does not change much and prefers to wait for the report and see where shares settle afterward.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.